Bortezomib, Cladribine, and Rituximab in Treating Patients With Advanced Mantle Cell Lymphoma or Indolent Lymphoma
Clinical trial NCT00980395 · COMPLETED
Trial details
- NCT number
- NCT00980395
- Sponsor
- University of Arizona
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-07
- Primary completion
- 2014-09-12
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.